Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT

ABSTRACTPericardial synovial sarcoma is an extremely rare tumor, and a challenging diagnosis due to nonspecific diverse presentation requiring a very strong clinical acumen along with an aggressive multimodal approach. Histopathological confirmation remains the gold standard. The optimal management...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nuclear medicine 2017-04, Vol.42 (4), p.315-318
Hauptverfasser: Jain, Avani S, Simon, Shelley, Muthukrishnan, Indirani, Gambhir, Aashish, Patil, Sushma
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 318
container_issue 4
container_start_page 315
container_title Clinical nuclear medicine
container_volume 42
creator Jain, Avani S
Simon, Shelley
Muthukrishnan, Indirani
Gambhir, Aashish
Patil, Sushma
description ABSTRACTPericardial synovial sarcoma is an extremely rare tumor, and a challenging diagnosis due to nonspecific diverse presentation requiring a very strong clinical acumen along with an aggressive multimodal approach. Histopathological confirmation remains the gold standard. The optimal management is unclear because of very few cases reported in literature. Herein, we describe the findings on contrast-enhanced FDG PET-CT facilitating the staging, lesion characterization, and timely response assessment to chemotherapy.
doi_str_mv 10.1097/RLU.0000000000001574
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1868686203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1868686203</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3564-d77578a429abe63e8f0aac5e3251a415c9501ae4246769a9227a489abe94f3b63</originalsourceid><addsrcrecordid>eNp9kE9Lw0AQxRdRbK1-A5EcvaTu_2SPEloVChZt8RimyYZEN9m6m1j67U1tFfHgzGEG5vfewEPokuAxwSq6eZotx_hXERHxIzQkgskQU6qO0RAzyUIVSTpAZ96_9owkkp-iAY2JEgrzIZrOtasycHkFJnjeNvbjawGX2RqCqTXGbnQeLNfBS9WWQWKb1oFvw0lTQpP1l_lkESaLc3RSgPH64jBHaDmdLJL7cPZ495DczsKMCcnDPIpEFAOnClZaMh0XGCATmlFBgBORKYEJaE65jKQCRWkEPN7BihdsJdkIXe99186-d9q3aV35TBsDjbadT0ksd00x61G-RzNnvXe6SNeuqsFtU4LTXYJpn2D6N8FednX40K1qnf-IviPrgXgPbKxptfNvpttol5YaTFv-7_0Jg9B7Bg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1868686203</pqid></control><display><type>article</type><title>Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>Jain, Avani S ; Simon, Shelley ; Muthukrishnan, Indirani ; Gambhir, Aashish ; Patil, Sushma</creator><creatorcontrib>Jain, Avani S ; Simon, Shelley ; Muthukrishnan, Indirani ; Gambhir, Aashish ; Patil, Sushma</creatorcontrib><description>ABSTRACTPericardial synovial sarcoma is an extremely rare tumor, and a challenging diagnosis due to nonspecific diverse presentation requiring a very strong clinical acumen along with an aggressive multimodal approach. Histopathological confirmation remains the gold standard. The optimal management is unclear because of very few cases reported in literature. Herein, we describe the findings on contrast-enhanced FDG PET-CT facilitating the staging, lesion characterization, and timely response assessment to chemotherapy.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/RLU.0000000000001574</identifier><identifier>PMID: 28195904</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Fluorodeoxyglucose F18 ; Heart Neoplasms - diagnostic imaging ; Humans ; Male ; Pericardium - diagnostic imaging ; Positron Emission Tomography Computed Tomography ; Radiopharmaceuticals ; Sarcoma, Synovial - diagnostic imaging ; Young Adult</subject><ispartof>Clinical nuclear medicine, 2017-04, Vol.42 (4), p.315-318</ispartof><rights>Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3564-d77578a429abe63e8f0aac5e3251a415c9501ae4246769a9227a489abe94f3b63</citedby><cites>FETCH-LOGICAL-c3564-d77578a429abe63e8f0aac5e3251a415c9501ae4246769a9227a489abe94f3b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28195904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jain, Avani S</creatorcontrib><creatorcontrib>Simon, Shelley</creatorcontrib><creatorcontrib>Muthukrishnan, Indirani</creatorcontrib><creatorcontrib>Gambhir, Aashish</creatorcontrib><creatorcontrib>Patil, Sushma</creatorcontrib><title>Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>ABSTRACTPericardial synovial sarcoma is an extremely rare tumor, and a challenging diagnosis due to nonspecific diverse presentation requiring a very strong clinical acumen along with an aggressive multimodal approach. Histopathological confirmation remains the gold standard. The optimal management is unclear because of very few cases reported in literature. Herein, we describe the findings on contrast-enhanced FDG PET-CT facilitating the staging, lesion characterization, and timely response assessment to chemotherapy.</description><subject>Fluorodeoxyglucose F18</subject><subject>Heart Neoplasms - diagnostic imaging</subject><subject>Humans</subject><subject>Male</subject><subject>Pericardium - diagnostic imaging</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Radiopharmaceuticals</subject><subject>Sarcoma, Synovial - diagnostic imaging</subject><subject>Young Adult</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9Lw0AQxRdRbK1-A5EcvaTu_2SPEloVChZt8RimyYZEN9m6m1j67U1tFfHgzGEG5vfewEPokuAxwSq6eZotx_hXERHxIzQkgskQU6qO0RAzyUIVSTpAZ96_9owkkp-iAY2JEgrzIZrOtasycHkFJnjeNvbjawGX2RqCqTXGbnQeLNfBS9WWQWKb1oFvw0lTQpP1l_lkESaLc3RSgPH64jBHaDmdLJL7cPZ495DczsKMCcnDPIpEFAOnClZaMh0XGCATmlFBgBORKYEJaE65jKQCRWkEPN7BihdsJdkIXe99186-d9q3aV35TBsDjbadT0ksd00x61G-RzNnvXe6SNeuqsFtU4LTXYJpn2D6N8FednX40K1qnf-IviPrgXgPbKxptfNvpttol5YaTFv-7_0Jg9B7Bg</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Jain, Avani S</creator><creator>Simon, Shelley</creator><creator>Muthukrishnan, Indirani</creator><creator>Gambhir, Aashish</creator><creator>Patil, Sushma</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT</title><author>Jain, Avani S ; Simon, Shelley ; Muthukrishnan, Indirani ; Gambhir, Aashish ; Patil, Sushma</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3564-d77578a429abe63e8f0aac5e3251a415c9501ae4246769a9227a489abe94f3b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Fluorodeoxyglucose F18</topic><topic>Heart Neoplasms - diagnostic imaging</topic><topic>Humans</topic><topic>Male</topic><topic>Pericardium - diagnostic imaging</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Radiopharmaceuticals</topic><topic>Sarcoma, Synovial - diagnostic imaging</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jain, Avani S</creatorcontrib><creatorcontrib>Simon, Shelley</creatorcontrib><creatorcontrib>Muthukrishnan, Indirani</creatorcontrib><creatorcontrib>Gambhir, Aashish</creatorcontrib><creatorcontrib>Patil, Sushma</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jain, Avani S</au><au>Simon, Shelley</au><au>Muthukrishnan, Indirani</au><au>Gambhir, Aashish</au><au>Patil, Sushma</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>42</volume><issue>4</issue><spage>315</spage><epage>318</epage><pages>315-318</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><abstract>ABSTRACTPericardial synovial sarcoma is an extremely rare tumor, and a challenging diagnosis due to nonspecific diverse presentation requiring a very strong clinical acumen along with an aggressive multimodal approach. Histopathological confirmation remains the gold standard. The optimal management is unclear because of very few cases reported in literature. Herein, we describe the findings on contrast-enhanced FDG PET-CT facilitating the staging, lesion characterization, and timely response assessment to chemotherapy.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>28195904</pmid><doi>10.1097/RLU.0000000000001574</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9762
ispartof Clinical nuclear medicine, 2017-04, Vol.42 (4), p.315-318
issn 0363-9762
1536-0229
language eng
recordid cdi_proquest_miscellaneous_1868686203
source MEDLINE; Journals@Ovid Ovid Autoload
subjects Fluorodeoxyglucose F18
Heart Neoplasms - diagnostic imaging
Humans
Male
Pericardium - diagnostic imaging
Positron Emission Tomography Computed Tomography
Radiopharmaceuticals
Sarcoma, Synovial - diagnostic imaging
Young Adult
title Pericardial Synovial Sarcoma Followed Up With Contrast-Enhanced PET-CT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T12%3A57%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pericardial%20Synovial%20Sarcoma%20Followed%20Up%20With%20Contrast-Enhanced%20PET-CT&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=Jain,%20Avani%20S&rft.date=2017-04-01&rft.volume=42&rft.issue=4&rft.spage=315&rft.epage=318&rft.pages=315-318&rft.issn=0363-9762&rft.eissn=1536-0229&rft_id=info:doi/10.1097/RLU.0000000000001574&rft_dat=%3Cproquest_cross%3E1868686203%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1868686203&rft_id=info:pmid/28195904&rfr_iscdi=true